References 1. Inspections, compliance, enforcement, and criminal investigations: Novartis International AG 11/18/11 [warning letter]. Silver Spring (MD): Food and Drug Administration (US); 2011 Nov 18 [cited 2012 Sep 20]. Available from: www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm281843.htm 2. Lettre aux clients (15-16 février). Boucherville (QC): Sandoz Canada Inc.; 2012 Feb 15 [ci...